Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Provectus Biopharmaceuticals Inc PVCT

Provectus Biopharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing immunotherapy medicines for different diseases that are based on a class of synthetic small-molecule immuno-catalysts called halogenated xanthenes (HXs). The Company’s lead molecule is named rose bengal sodium (RBS). The Company’s small molecule HX medical science platform... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (OTCQB:PVCT)

Provectus Biopharmaceuticals Announces Publication of Preclinical Data of Oral Administration of Provectus Rose Bengal for Solid Tumor Cancers

GlobeNewswire 1 day ago

Provectus Biopharmaceuticals Announces Management Additions and Reiterates Commitment to Shareholder Value Creation

GlobeNewswire 3 days ago

Provectus Biopharmaceuticals Announces Presentation of Cancer Immunotherapy PV-10 Poster for HNSCC at AACR 2024 Annual Meeting

GlobeNewswire 8 days ago

Provectus Biopharmaceuticals Announces Exclusive Worldwide License Agreement with University of Miami for Photodynamic Antimicrobial Treatment of Different Eye Infections with Rose Bengal Sodium

GlobeNewswire March 27, 2024

Provectus Biopharmaceuticals Announces Notices of Allowance and Award for U.S. Patents of Rose Bengal Sodium in Virology, Pediatric Solid Tumor Cancers, and Vaccines

GlobeNewswire March 12, 2024

Provectus Biopharmaceuticals Announces Acceptance of Cancer Immunotherapy PV-10 Abstract for HNSCC at AACR 2024 Annual Meeting

GlobeNewswire March 7, 2024

Provectus Biopharmaceuticals Announces Acceptance of Pharmaceutical-Grade Rose Bengal Sodium Abstract for Poster Presentation at 2024 Society for Investigative Dermatology (SID) Annual Meeting

GlobeNewswire February 29, 2024

Provectus Biopharmaceuticals Announces First Quarter 2024 Conference Call

GlobeNewswire February 15, 2024

Provectus Biopharmaceuticals Engages irlabs for Investor Relations Services

GlobeNewswire February 14, 2024

Opinion & Analysis (OTCQB:PVCT)

No current opinion is available.

Bullboard Posts (OTCQB:PVCT)

RE:RE:PVCT is not dead yet

Follow on their substack page: substack.provectus.com Interesting developments the past year re Bascom Palmer trial and pending Mets to...
tdon1229 - March 21, 2024

RE:PVCT is not dead yet

3 years but who's counting lol. Now it's 5 years from ur post and trading at the same share price. Done a little DD and on my...
Thecook100 - May 21, 2022

Where does it go from here

Looks like it may get wings!?!?!??!?!?!?
fastedster - December 29, 2017

PVCT is not dead yet

It has been 2 years since the last post and PVCT is not dead yet. In fact, though it is still in the toilet, it is looking better than it...
mplaut - June 14, 2017

PVCT

Good article about PVCT  Seeking Alpha Asks Longs for Proof and Believes Shorts' Allegations Without Investigating. ...
funnyzguy - June 17, 2014

TD Ameritrade Trading Halt in PVCT

If you were a customer of TD Ameritrade and could not sell shares of PVCT on January 23, 2014, please contact us. Our law firm has been...
greenlegalteam - June 4, 2014